RT @autismcrisis: Lovastatin (vs placebo) does not benefit FXS youth aged 10-17 https://t.co/5Svox7x7yi 20 week RCT, planned N=104 but actu…
13,303 followers
9,543 followers
Lovastatin (vs placebo) does not benefit FXS youth aged 10-17 https://t.co/5Svox7x7yi 20 week RCT, planned N=104 but actual N=30, autism-relevant, free
5,487 followers
Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome. https://t.co/GCGqhjw41q PubMed
1,659 followers
Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome https://t.co/232xO76S0p